Home About us Contact | |||
New Prospects (new + prospect)
Selected AbstractsThe Return of Non-DAC Donors to Africa: New Prospects for African Development?DEVELOPMENT POLICY REVIEW, Issue 5 2008Peter Kragelund This article examines the consequences of the return to Africa of donors that are not members of the OECD's Development Assistance Committee (DAC). It categorises these donors according to form, content, size and modality of their aid. It finds that their return increases external financial flows, in particular to countries not targeted by DAC donors. Moreover, for some donors like China and India the flows are closely related to other financial flow s such as trade and investment. Furthermore, it finds that the return of non-DAC donors may conflict with plans to harmonise aid and may simultaneously raise transaction costs for recipients. [source] New prospects for immunotherapy at diagnosis of type 1 diabetesDIABETES/METABOLISM: RESEARCH AND REVIEWS, Issue 4 2009Paolo Pozzilli Immune intervention at diagnosis of type 1 diabetes (T1D) aims to prevent or reverse the disease by blocking autoimmunity, thereby preserving/restoring ,-cell mass and function. Recent clinical trials of non-specific and of antigen-specific immune therapies have demonstrated the feasibility of modulation of islet-specific autoimmunity in patients with partial prevention of loss of insulin secretion. In a series of review articles published in this issue of the journal, some of the most promising approaches of immune intervention in T1D are presented. Here we outline the rationale of such interventions and future prospects in this area. Copyright © 2009 John Wiley & Sons, Ltd. Insulin therapy in type 1 diabetes (T1D) rescues the patient from a certain death but not cure the disease. The goal of any therapeutic intervention in T1D is the preservation of insulin-secreting cells; this is achieved by the abrogation of pathogenic reactivity to beta cell autoantigens while preserving full capacity to generate a normal immune response against foreign antigens. Although several therapeutic candidates have been investigated in experimental models of T1D many of which showed promising results, a successful extrapolation of these findings to human T1D has proved to be difficult. In part, this failure results from the considerable disease heterogeneity associated with diverse genetic and non-genetic disease determinants and the spectrum of clinical phenotype at diagnosis. Thus, a younger age at onset is associated with stronger genetic susceptibility, more intense immune response to ,-cell antigens, shorter duration of symptoms, more severe metabolic derangement at diagnosis and a more rapid rate of ,-cell-destruction 1,3. Therefore, designing therapies that would be effective in all clinical settings is definitely challenging. In this issue five different approaches are discussed ranging from antigen-specific therapies [DiaPep277 and glutamic acid decarboxylase(GAD)], to non-antigen-specific immunoregulation (anti-CD3) and to anti-inflammatory (anti-IL1 receptor antagonist). These approaches are currently being tested in large international multicenter trials, and all of them use very similar outcome in terms of a beneficial effect (C-peptide secretion as evidence of a therapeutic effect on restoration of ,-cell function). The authors have been asked to follow a similar format in presenting their approaches so that the reader can easily compare them in terms of rationale and therapeutic goals. [source] Two new lipoaminoacids with complementary modes of action: new prospects to fight out against skin agingINTERNATIONAL JOURNAL OF COSMETIC SCIENCE, Issue 1 2010S. Dumont Synopsis The mode of action of two cosmetic active ingredients (AIs), palmitoyl glycine (PG) and cocoyl alanine (CA) was studied with cDNA array experiments and quantitative PCR confirmations, which were performed on experimentally aged human fibroblasts. These preliminary studies revealed complementary profiles. Thus, specific supplementary investigations were then carried out for each AI. Protocols used were based either on in vitro models: (i) biochemical assays, (ii) monolayer cell culture (primary human fibroblasts and keratinocytes) and (iii) the model of capillary-like tube formation by human endothelial cells or on ex vivo models, i.e. topically treated skin explants and both immunohistochemical and ChromameterTM investigations. New prospects are proposed to fight out against skin aging. Indeed, PG and CA showed complementary properties and thus enabled a regulation or a restoration effect on main aging-associated disorders. Thus, they can not only act on tissue architecture, cell,cell interactions and extracellular matrix protection but also on inflammation, cell longevity, skin immune system protection, skin radiance and stem cell survey. Finally, a clinical trial performed on Caucasian women confirmed AI anti-wrinkle efficacy, which was superior to that of a market reference ingredient. In the future, complementary experiments enabling a better understanding of the aging-induced decline of epidermal stem cells would be of a great interest. Résumé Le mode d'action de deux actifs cosmétiques, Palmitoyl glycine (PG) et Cocoyl Alanine (CA), a été déterminéà l'aide d'expériences de cDNA arrays et de confirmations par qPCR, réalisées sur des fibroblastes humains vieillis expérimentalement. Ces études préliminaires ont révélé des modes d'action complémentaires. Des expériences supplémentaires spécifiques ont donc ensuite été réalisées pour chaque actif. Les protocoles utilisés étaient basés sur des modèles in vitro: i) études biochimiques, ii) cultures cellulaires en monocouches (cultures primaires de fibroblastes et de kératinocytes humains) et iii) modèle de formation de pseudo-tubules par des cellules endothéliales humaines; ou sur des modèles ex-vivo, i.e. des explants de peau traités de manière topique et analysés à l'aide d'études immuno-histochimiques et d'un ChromamètreTM. De nouvelles perspectives s'ouvrent pour combattre le vieillissement cutané. En effet, PG et CA montrent des propriétés complémentaires et permettent ainsi une régulation ou une restauration des principaux dysfonctionnements liés à l'âge. Ainsi, ils peuvent agir non-seulement sur l'architecture des tissus, l'interaction entre les cellules et la protection de la matrice extracellulaire mais aussi sur l'inflammation, la longévité cellulaire, la survie des cellules souches, le système de protection immunitaire et l'éclat de la peau. Finalement, des essais cliniques réalisés sur des femmes de type Caucasien ont confirmé l'efficacité antirides des actifs, laquelle était supérieure à celle d'une référence anti-âge du marché. Dans un futur proche, des tests complémentaires pourraient permettre une meilleure compréhension de la dégradation des cellules souches épidermiques au cours du vieillissement. [source] New prospects for autoimmune disease therapy: B cells on deathwatchARTHRITIS & RHEUMATISM, Issue 1 2006E. William St.Clair First page of article [source] Vitamin D and muscle function: New prospects?BIOFACTORS, Issue 1 2009Cédric Annweiler MD No abstract is available for this article. [source] A Multiscale Description of the Electronic Transport within the Hierarchical Architecture of a Composite Electrode for Lithium BatteriesADVANCED FUNCTIONAL MATERIALS, Issue 17 2009Jean-Claude Badot Abstract The broadband dielectric spectroscopy technique is applied, for the first time, to a composite material used as an electrode for lithium battery. The electrical properties (permittivity and conductivity) are measured from low (a few Hz) to microwave (a few GHz) frequencies. The results demonstrate that the broadband dielectric spectroscopy technique is very sensitive to the different scales of the electrode architecture involved in electronic transport, from interatomic distances to macroscopic sizes, as well as to the morphology at these scales, coarse or fine distribution of the constituents. This work opens up new prospects for a more fundamental understanding and more rational optimization of the electronic transport in composite electrodes for lithium batteries and other electrochemical energy storage technologies (including other batteries, supercapacitors, low- and medium-temperature fuel cells), electrochemical sensors and conductor,insulator composite materials. [source] Two new lipoaminoacids with complementary modes of action: new prospects to fight out against skin agingINTERNATIONAL JOURNAL OF COSMETIC SCIENCE, Issue 1 2010S. Dumont Synopsis The mode of action of two cosmetic active ingredients (AIs), palmitoyl glycine (PG) and cocoyl alanine (CA) was studied with cDNA array experiments and quantitative PCR confirmations, which were performed on experimentally aged human fibroblasts. These preliminary studies revealed complementary profiles. Thus, specific supplementary investigations were then carried out for each AI. Protocols used were based either on in vitro models: (i) biochemical assays, (ii) monolayer cell culture (primary human fibroblasts and keratinocytes) and (iii) the model of capillary-like tube formation by human endothelial cells or on ex vivo models, i.e. topically treated skin explants and both immunohistochemical and ChromameterTM investigations. New prospects are proposed to fight out against skin aging. Indeed, PG and CA showed complementary properties and thus enabled a regulation or a restoration effect on main aging-associated disorders. Thus, they can not only act on tissue architecture, cell,cell interactions and extracellular matrix protection but also on inflammation, cell longevity, skin immune system protection, skin radiance and stem cell survey. Finally, a clinical trial performed on Caucasian women confirmed AI anti-wrinkle efficacy, which was superior to that of a market reference ingredient. In the future, complementary experiments enabling a better understanding of the aging-induced decline of epidermal stem cells would be of a great interest. Résumé Le mode d'action de deux actifs cosmétiques, Palmitoyl glycine (PG) et Cocoyl Alanine (CA), a été déterminéà l'aide d'expériences de cDNA arrays et de confirmations par qPCR, réalisées sur des fibroblastes humains vieillis expérimentalement. Ces études préliminaires ont révélé des modes d'action complémentaires. Des expériences supplémentaires spécifiques ont donc ensuite été réalisées pour chaque actif. Les protocoles utilisés étaient basés sur des modèles in vitro: i) études biochimiques, ii) cultures cellulaires en monocouches (cultures primaires de fibroblastes et de kératinocytes humains) et iii) modèle de formation de pseudo-tubules par des cellules endothéliales humaines; ou sur des modèles ex-vivo, i.e. des explants de peau traités de manière topique et analysés à l'aide d'études immuno-histochimiques et d'un ChromamètreTM. De nouvelles perspectives s'ouvrent pour combattre le vieillissement cutané. En effet, PG et CA montrent des propriétés complémentaires et permettent ainsi une régulation ou une restauration des principaux dysfonctionnements liés à l'âge. Ainsi, ils peuvent agir non-seulement sur l'architecture des tissus, l'interaction entre les cellules et la protection de la matrice extracellulaire mais aussi sur l'inflammation, la longévité cellulaire, la survie des cellules souches, le système de protection immunitaire et l'éclat de la peau. Finalement, des essais cliniques réalisés sur des femmes de type Caucasien ont confirmé l'efficacité antirides des actifs, laquelle était supérieure à celle d'une référence anti-âge du marché. Dans un futur proche, des tests complémentaires pourraient permettre une meilleure compréhension de la dégradation des cellules souches épidermiques au cours du vieillissement. [source] Origin of multifocal carcinomas of the bladder and upper urinary tract: Molecular analysis and clinical implicationsINTERNATIONAL JOURNAL OF UROLOGY, Issue 8 2005TOMONORI HABUCHI Abstract The simultaneous or metachronous development of multifocal tumors with identical or variable histological features in the urothelial tract in a single patient is a well-known characteristic of urothelial cancer. To explain this phenomenon, two distinct concepts have been proposed: the ,field defect' hypothesis according to which urothelial cells in patients are primed to undergo transformation by previous carcinogenic insults and the ,single progenitor cell' hypothesis, which asserts that the multifocal development is caused by the seeding or intraepithelial spread of transformed cells. Results of recent molecular genetic studies support the ,single progenitor cell' hypothesis, and indicate that the genetic and phenotypic diversity observed in multifocal urothelial tumors is a consequence of clonal evolution from a single transformed cell. An understanding of the mechanism of the heterotopic recurrence of urothelial cancer may provide new prospects for early molecular detection and prevention of heterotopic recurrence of urothelial cancer. [source] Fungal tyrosinases: new prospects in molecular characteristics, bioengineering and biotechnological applicationsJOURNAL OF APPLIED MICROBIOLOGY, Issue 2 2006S. Halaouli Abstract Tyrosinases are type-3 copper proteins involved in the initial step of melanin synthesis. These enzymes catalyse both the o -hydroxylation of monophenols and the subsequent oxidation of the resulting o -diphenols into reactive o -quinones, which evolve spontaneously to produce intermediates, which associate in dark brown pigments. In fungi, tyrosinases are generally associated with the formation and stability of spores, in defence and virulence mechanisms, and in browning and pigmentation. First characterized from the edible mushroom Agaricus bisporus because of undesirable enzymatic browning problems during postharvest storage, tyrosinases were found, more recently, in several other fungi with relevant insights into molecular and genetic characteristics and into reaction mechanisms, highlighting their very promising properties for biotechnological applications. The limit of these applications remains in the fact that native fungal tyrosinases are generally intracellular and produced in low quantity. This review compiles the recent data on biochemical and molecular properties of fungal tyrosinases, underlining their importance in the biotechnological use of these enzymes. Next, their most promising applications in food, pharmaceutical and environmental fields are presented and the bioengineering approaches used for the development of tyrosinase-overproducing fungal strains are discussed. [source] Anti-inflammatory, analgesic and anti-oedematous effects of Lafoensia pacari extract and ellagic acidJOURNAL OF PHARMACY AND PHARMACOLOGY: AN INTERNATI ONAL JOURNAL OF PHARMACEUTICAL SCIENCE, Issue 9 2006Alexandre P. Rogerio Lafoensia pacari St. Hil. (Lythraceae) is used in traditional medicine to treat inflammation. Previously, we demonstrated the anti-inflammatory effect that the ethanolic extract of L. pacari has in Toxocara canis infection (a model of systemic eosinophilia). In this study, we tested the antiinflammatory activity of the same L. pacari extract in mice injected intraperitoneally with ,-glucan present in fraction 1 (F1) of the Histoplasma capsulatum cell wall (a model of acute eosinophilic inflammation). We also determined the anti-oedematous, analgesic and anti-pyretic effects of L. pacari extract in carrageenan-induced paw oedema, acetic acid writhing and LPS-induced fever, respectively. L. pacari extract significantly inhibited leucocyte recruitment into the peritoneal cavity induced by ,-glucan. In addition, the L. pacari extract presented significant analgesic, anti-oedematous and anti-pyretic effects. Bioassay-guided fractionation of the L. pacari extract in the F1 model led us to identify ellagic acid. As did the extract, ellagic acid presented anti-inflammatory, anti-oedematous and analgesic effects. However, ellagic acid had no anti-pyretic effect, suggesting that other compounds present in the plant stem are responsible for this effect. Nevertheless, our results demonstrate potential therapeutic effects of L. pacari extract and ellagic acid, providing new prospects for the development of drugs to treat pain, oedema and inflammation. [source] Économie sociale et nouveaux pays industrialisés: Le cas de la Corée du sudANNALS OF PUBLIC AND COOPERATIVE ECONOMICS, Issue 3 2000Eric Bidet For more than 30 years, South Korea has experienced exceptional economic growth. In the context of such an accomplishment, is any room left for the social economy organizations? The analysis of available legal and economic data shows that whereas these organizations have a nonnegligible place in the Korean economy, on the one hand their role is limited in comparison with their western counterparts, and on the other hand the boundaries between public, capitalist and social economy sectors are blurred. The family in Korea is the most natural factor of socio-economic integration; in many areas the family substitutes for intermediaries like the social economy organizations. The economic crisis that touched Korea at the end of 1997 contributed to the weakening of the traditional model of family solidarity and offered new prospects for the Korean social economy, especially in the field of social protection and social services. This is similar to what seems to be evolving in Europe. [source] |